$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000143774923006178 Filed on March 10, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.185M	$235.0K	$3.975M
YoY Change	-3.97%	-461.54%	-33.23%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.185M	$235.0K	$3.975M
YoY Change	-3.97%	-461.54%	-33.23%
Operating Profit	-$1.185M	-$1.035M	-$4.775M
YoY Change	-3.97%	-8.81%	93.87%
Interest Expense	-$2.290M	-$3.520M	-$6.191M
YoY Change	-34.16%	133.58%	-151.07%
% of Operating Profit
Other Income/Expense, Net	-$9.000K	-$318.0K	-$3.297M
YoY Change	-99.55%	-94.69%	-567.0%
Pretax Income	-$3.484M	-$4.873M	-$14.26M
YoY Change	-48.07%	-43.56%	-180.92%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.484M	-$4.873M	-$14.26M
YoY Change	-48.07%	-43.56%	-180.92%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.22	-$0.30	-$0.87
Diluted Earnings Per Share	-$0.22	-$0.30	-$0.87
COMMON SHARES
Basic Shares Outstanding	16.27M	16.32M	16.34M
Diluted Shares Outstanding	16.07K		16.34M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.80M	$19.33M	$19.29M
YoY Change	-3.13%	-21.86%	-22.04%
Cash & Equivalents	$11.00M	$13.33M	$13.33M
Short-Term Investments	$7.800M	$6.000M	$5.956M
Other Short-Term Assets	$1.370M	$2.136M	$2.136M
YoY Change	-60.76%	-61.44%	-61.44%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$20.14M	$21.42M	$21.42M
YoY Change	-12.05%	-29.25%	-29.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.215M	$1.290M	$1.290M
YoY Change	-18.84%	-17.36%	-17.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.180M	$8.846M	$14.55M
YoY Change	-58.76%	-58.29%	-33.8%
Other Assets	$383.0K	$434.0K	$434.0K
YoY Change	66.52%	100.0%	100.0%
Total Long-Term Assets	$13.59M	$16.27M	$16.27M
YoY Change	-41.68%	-31.5%	-31.5%
TOTAL ASSETS
Total Short-Term Assets	$20.14M	$21.42M	$21.42M
Total Long-Term Assets	$13.59M	$16.27M	$16.27M
Total Assets	$33.73M	$37.69M	$37.69M
YoY Change	-26.99%	-30.24%	-30.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$71.00K	$16.00K	$16.00K
YoY Change		-60.98%	-60.98%
Accrued Expenses	$539.0K	$865.0K	$1.801M
YoY Change	-2.0%	65.08%	6.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.152M	$1.817M	$1.817M
YoY Change	14.06%	4.79%	4.79%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$50.00K	$50.00K	$1.299M
YoY Change	0.0%	0.0%	-24.83%
Total Long-Term Liabilities	$50.00K	$50.00K	$1.299M
YoY Change	0.0%	0.0%	-24.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.152M	$1.817M	$1.817M
Total Long-Term Liabilities	$50.00K	$50.00K	$1.299M
Total Liabilities	$2.335M	$3.116M	$3.116M
YoY Change	-11.85%	-9.99%	-9.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$727.4M	-$723.9M
YoY Change	1.54%	2.01%
Common Stock	$805.2M	$806.9M
YoY Change	-0.34%	-0.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$48.41M
YoY Change		-0.33%
Treasury Stock Shares		$5.478M
Shareholders Equity	$31.39M	$34.58M	$34.58M
YoY Change
Total Liabilities & Shareholders Equity	$33.73M	$37.69M	$37.69M
YoY Change	-26.99%	-30.24%	-30.24%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$3.484M	-$4.873M	-$14.26M
YoY Change	-48.07%	-43.56%	-180.92%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$928.0K	-$598.0K	-$3.258M
YoY Change	-7.29%	-77.92%	-60.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.090M	-$199.0K	-$4.662M
YoY Change	-64.86%	-108.75%	-108.02%
Cash From Investing Activities	-$1.090M	-$199.0K	-$4.662M
YoY Change	-64.86%	-108.75%	-108.02%
FINANCING ACTIVITIES
Cash Dividend Paid			$0.00
YoY Change
Common Stock Issuance & Retirement, Net			$2.939M
YoY Change			-92.77%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$305.0K	-905.0K	-$3.488M
YoY Change	-75.18%	-97.68%	-91.45%
NET CHANGE
Cash From Operating Activities	-$928.0K	-598.0K	-$3.258M
Cash From Investing Activities	-$1.090M	-199.0K	-$4.662M
Cash From Financing Activities	-$305.0K	-905.0K	-$3.488M
Net Change In Cash	-$2.323M	-1.702M	-$11.41M
YoY Change	-56.43%	-95.69%	-224.5%
FREE CASH FLOW
Cash From Operating Activities	-$928.0K	-$598.0K	-$3.258M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Radnor
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19087
CY2022	dei	City Area Code CityAreaCode	610
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2157000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2157000	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5478000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5068000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	500000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	usd
CY2022Q4	sfe	Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Award Vesting Types SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfAwardVestingTypes	2	pure
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0.0	usd
CY2021	sfe	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Negative Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateNegativeRatePercent	0.210	pure
CY2022	sfe	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Negative Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateNegativeRatePercent	0.210	pure
CY2021	sfe	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Negative Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateNegativeRatePercent	0.210	pure
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	1-5620
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-1609753
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	150 N. Radnor Chester Road
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	806638000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	48410000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	48569000	usd
CY2022	dei	Local Phone Number LocalPhoneNumber	293-0600
CY2022	dei	Security12b Title Security12bTitle	Common Stock ($.10 par value)
CY2022	dei	Trading Symbol TradingSymbol	SFE
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	50494095	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16268270
CY2022	dei	Auditor Firm AuditorFirmId	248
CY2022	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2022	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13331000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24739000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	25000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5956000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2022Q4	us-gaap	Trading Securities TradingSecurities	860000	usd
CY2021Q4	us-gaap	Trading Securities TradingSecurities	4549000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1251000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	965000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21423000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	30278000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1290000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1561000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	14545000	usd
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	21972000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	434000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	217000	usd
CY2022Q4	us-gaap	Assets Assets	37692000	usd
CY2021Q4	us-gaap	Assets Assets	54028000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	41000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	507000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	794000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	865000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	524000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	429000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	375000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1817000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1734000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1249000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-723898000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1678000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	50000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	50000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3116000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3462000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	804752000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-709635000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34576000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	50566000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37692000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54028000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4775000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7153000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4775000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-7153000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3297000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	22035000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	794000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	276000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6985000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11846000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14263000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	27004000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	27004000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.36
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.36
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16337000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19827000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16337000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19827000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	62875000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	27004000	usd
CY2021	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	-736000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	606000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	40655000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	50566000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2022	sfe	Stock Issued During Period Value Restricted Stock Award Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes	477000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	736000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2940000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34576000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	27004000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	271000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	229000	usd
CY2022	sfe	Income Loss From Equity Method Investments Excluding Impairments IncomeLossFromEquityMethodInvestmentsExcludingImpairments	-6985000	usd
CY2021	sfe	Income Loss From Equity Method Investments Excluding Impairments IncomeLossFromEquityMethodInvestmentsExcludingImpairments	11846000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-0	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2521000	usd
CY2022	sfe	Gain Loss From Observable Price Changes GainLossFromObservablePriceChanges	553000	usd
CY2021	sfe	Gain Loss From Observable Price Changes GainLossFromObservablePriceChanges	8505000	usd
CY2022	sfe	Gain From Sale Of Ownership Interests GainFromSaleOfOwnershipInterests	-0	usd
CY2021	sfe	Gain From Sale Of Ownership Interests GainFromSaleOfOwnershipInterests	35284000	usd
CY2022	sfe	Increase Decrease In Fair Value Of Ownership Interests IncreaseDecreaseInFairValueOfOwnershipInterests	-3689000	usd
CY2021	sfe	Increase Decrease In Fair Value Of Ownership Interests IncreaseDecreaseInFairValueOfOwnershipInterests	-19255000	usd
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-76000	usd
CY2021	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	22000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1445000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1779000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	534000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	238000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-374000	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-3045000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3258000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8152000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	6879000	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	60832000	usd
CY2022	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	5670000	usd
CY2021	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	2718000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	11871000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	6000000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4662000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	58114000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2939000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	40655000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	549000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	144000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3488000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40799000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11408000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	9163000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24764000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15601000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13356000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24764000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13300000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	6000000.0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	180000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Accounting Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results <em style="font: inherit;"> may </em>differ from these estimates. These estimates include the evaluation of the recoverability of the Company’s ownership interests and advances, the recoverability of deferred tax assets, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Certain amounts recorded to reflect the Company’s share of income or losses for companies accounted for under the equity method are based on unaudited results of operations of those companies and <em style="font: inherit;"> may </em>require adjustments in the future when audits of these entities’ financial statements are completed.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">It is reasonably possible that the Company’s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company’s ownership interests and advances could change in the near term and that the effect of such changes on the consolidated financial statements could be material. At <em style="font: inherit;"> December 31, 2022</em>, the Company believes the carrying value of the Company’s ownership interests and advances is <em style="font: inherit;">not</em> impaired, although there can be <em style="font: inherit;">no</em> assurance that the Company’s future results will confirm this assessment, that a significant write-down or write-off will <em style="font: inherit;">not</em> be required in the future or that a significant loss will <em style="font: inherit;">not</em> be recorded in the future upon the sale of a company.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"/>
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13331000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24739000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	25000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	25000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13356000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24764000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	268000	usd
CY2020Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.12	pure
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	500000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	607000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	556000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	613000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	573000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	619000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	590000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	207000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	199000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	0	usd
CY2022Q4	sfe	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	0	usd
CY2022Q4	sfe	Lessor Operating Lease Payments To Be Received Six Years LessorOperatingLeasePaymentsToBeReceivedSixYears	0	usd
CY2022Q4	sfe	Lessee Operating Lease Liability To Be Paid After Year Six LesseeOperatingLeaseLiabilityToBePaidAfterYearSix	0	usd
CY2022Q4	sfe	Lessor Operating Lease Payment To Be Received After Year Six LessorOperatingLeasePaymentToBeReceivedAfterYearSix	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2046000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1918000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	368000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1678000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8846000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	21208000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	2177000	usd
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5313000	usd
CY2022Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	4382000	usd
CY2021Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	0	usd
CY2022Q4	sfe	Investments And Advances To Affiliates Current And Noncurrent InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent	15405000	usd
CY2021Q4	sfe	Investments And Advances To Affiliates Current And Noncurrent InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent	26521000	usd
CY2021	sfe	Impairment Of Other Method Securities ImpairmentOfOtherMethodSecurities	2500000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-106000	usd
CY2022Q4	sfe	Equity Method Investment Assets Exceed Carrying Value Of Investment EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment	2700000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1445000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1779000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	136000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1	pure
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.05	pure
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0.0	usd
CY2022	sfe	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Negative Rate Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateNegativeRatePercent	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.026	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.033	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.236	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.243	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	33222000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	31985000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	68492000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	77045000	usd
CY2022Q4	sfe	Deferred Tax Asset Disallowed Interest Carryforwards DeferredTaxAssetDisallowedInterestCarryforwards	6891000	usd
CY2021Q4	sfe	Deferred Tax Asset Disallowed Interest Carryforwards DeferredTaxAssetDisallowedInterestCarryforwards	7120000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	47000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	24000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	108726000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	116578000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	108726000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	116578000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	326000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	60000000	usd
CY2022Q4	sfe	Net Operating Loss Carryforwards Expiring In Year One NetOperatingLossCarryforwardsExpiringInYearOne	45830000	usd
CY2022Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Two NetOperatingLossCarryforwardsExpiringInYearTwo	50140000	usd
CY2022Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Three NetOperatingLossCarryforwardsExpiringInYearThree	17266000	usd
CY2022Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Four NetOperatingLossCarryforwardsExpiringInYearFour	7648000	usd
CY2022Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Five And Thereafter NetOperatingLossCarryforwardsExpiringInYearFiveAndThereafter	145275000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	266159000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	27004000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16337000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19827000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.36
CY2022	us-gaap	Profit Loss ProfitLoss	-14263000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	27004000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16337000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19827000
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.36
CY2022Q4	sfe	Employee And Severance Agreement Maximum Aggregate Exposure EmployeeAndSeveranceAgreementMaximumAggregateExposure	1100000	usd
CY2022	sfe	Employee And Severance Agreement Maximum Aggregate Exposure Shares EmployeeAndSeveranceAgreementMaximumAggregateExposureShares	250000
CY2021	sfe	Long Term Incentive Plan Payments LongTermIncentivePlanPayments	2500000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	0	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1000000.0	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1234000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1146000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1360000	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1035000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1234000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1146000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1360000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1035000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1997000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1012000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-318000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	101000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	145000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	230000	usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	318000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3579000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1454000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1022000	usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3838000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6709000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	483000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3164000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4873000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-6709000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	483000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-3164000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-4873000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1135000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2463000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1991000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1564000	usd
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1135000	usd
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2463000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1991000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1564000	usd
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	706000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6733000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	20588000	usd
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5992000	usd
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	53000	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	74000	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	70000	usd
CY2021Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	79000	usd
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19329000	usd
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5136000	usd
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-761000	usd
CY2021Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1586000	usd
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17625000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-320000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18333000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8634000	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	17625000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-320000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	18333000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-8634000	usd
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.84
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001437749-23-006178-index-headers.html	Edgar Link	pending
0001437749-23-006178-index.html	Edgar Link	pending
0001437749-23-006178.txt	Edgar Link	pending
0001437749-23-006178-xbrl.zip	Edgar Link	pending
ex_449898.htm	Edgar Link	pending
ex_449899.htm	Edgar Link	pending
ex_449901.htm	Edgar Link	pending
ex_449902.htm	Edgar Link	pending
ex_449903.htm	Edgar Link	pending
ex_449904.htm	Edgar Link	pending
ex_477546.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20221231.xsd	Edgar Link	pending
sfe20221231_10k.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sfe-20221231_cal.xml	Edgar Link	unprocessable
sfe-20221231_def.xml	Edgar Link	unprocessable
sfe-20221231_lab.xml	Edgar Link	unprocessable
sfe-20221231_pre.xml	Edgar Link	unprocessable
sfe20221231_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2023 Q1 Form 10-K Financial Statement

#000143774923006178 Filed on March 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2023 Q1 Form 10-K Financial Statement

#000143774923006178 Filed on March 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes